AU5398296A - Vaccine for the immunoprophylaxis of the infection from feli ne immunodeficiency virus in the domestic cat - Google Patents
Vaccine for the immunoprophylaxis of the infection from feli ne immunodeficiency virus in the domestic catInfo
- Publication number
- AU5398296A AU5398296A AU53982/96A AU5398296A AU5398296A AU 5398296 A AU5398296 A AU 5398296A AU 53982/96 A AU53982/96 A AU 53982/96A AU 5398296 A AU5398296 A AU 5398296A AU 5398296 A AU5398296 A AU 5398296A
- Authority
- AU
- Australia
- Prior art keywords
- feli
- immunoprophylaxis
- vaccine
- infection
- immunodeficiency virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000282326 Felis catus Species 0.000 title 1
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM95A0209 | 1995-03-31 | ||
IT95RM000209A IT1276509B1 (en) | 1995-03-31 | 1995-03-31 | VACCINE FOR THE IMMUNE PROPHYLAXY OF FELINE IMMUNODEFICIENCY VIRUS INFECTION OF DOMESTIC CAT. |
PCT/EP1996/001356 WO1996030045A1 (en) | 1995-03-31 | 1996-03-28 | Vaccine for the immunoprophylaxis of the infection from feline immunodeficiency virus in the domestic cat |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5398296A true AU5398296A (en) | 1996-10-16 |
Family
ID=11403226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53982/96A Abandoned AU5398296A (en) | 1995-03-31 | 1996-03-28 | Vaccine for the immunoprophylaxis of the infection from feli ne immunodeficiency virus in the domestic cat |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5398296A (en) |
IT (1) | IT1276509B1 (en) |
WO (1) | WO1996030045A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69636440D1 (en) | 1995-08-25 | 2006-09-21 | Univ Florida | IL-2 independent T cells of the cat |
US6254872B1 (en) | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
WO2004100985A2 (en) | 2003-05-12 | 2004-11-25 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against fiv infection |
US7658927B2 (en) | 2003-05-12 | 2010-02-09 | University Of Florida Research Foundation, Inc. | Materials and methods for immunizing against FIV infection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
WO1993001278A1 (en) * | 1991-07-05 | 1993-01-21 | The Regents Of The University Of California | Feline lymphoid cell lines capable of producing fiv |
IL104382A0 (en) * | 1992-01-17 | 1993-05-13 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant |
GB9219936D0 (en) * | 1992-09-21 | 1992-11-04 | Pitman Moore Inc | Vaccines |
EP0659885A1 (en) * | 1993-12-21 | 1995-06-28 | Akzo Nobel N.V. | Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
-
1995
- 1995-03-31 IT IT95RM000209A patent/IT1276509B1/en active IP Right Grant
-
1996
- 1996-03-28 AU AU53982/96A patent/AU5398296A/en not_active Abandoned
- 1996-03-28 WO PCT/EP1996/001356 patent/WO1996030045A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ITRM950209A1 (en) | 1996-10-01 |
WO1996030045A1 (en) | 1996-10-03 |
ITRM950209A0 (en) | 1995-03-31 |
IT1276509B1 (en) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4878096A (en) | Hepatitis b vaccine | |
AU6304996A (en) | Vaccines against hepatitis c | |
AU6093296A (en) | Infectious dengue 2 virus pdk-53 as quadravalent vaccine | |
HUP9601466A2 (en) | Adjuvants for viral vaccines | |
HUP9601462A2 (en) | Adjuvants for viral vaccines | |
LTIP335A (en) | Vaccine for human immunodeficiency virus | |
DZ1706A1 (en) | Hepatitis A vaccine. | |
ZA964679B (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
EP0967993A4 (en) | Anti-cocaine vaccine | |
AU7465696A (en) | Synthetic vaccine for protection against human immunodeficiency virus infection | |
AU2769595A (en) | Contraceptive vaccine | |
AU5679394A (en) | Hepatitis b virus vaccines | |
AU5398296A (en) | Vaccine for the immunoprophylaxis of the infection from feli ne immunodeficiency virus in the domestic cat | |
AU2370592A (en) | Epitopes of the env protein of the hepatitis c virus | |
AU4450696A (en) | Enhanced immunogenic vaccine | |
AU5240896A (en) | Marek's disease vaccine | |
AU5520796A (en) | Peptide-based vaccine against papillomavirus infection | |
AUPQ257199A0 (en) | Vaccine antigens of moraxella | |
AU7336296A (en) | Human hepatitis b virus dna | |
AU1111397A (en) | Sugar-chain-recognizing antibodies and remedies for HIV infectious diseases | |
AU4970193A (en) | IPNV vaccine | |
AU8096998A (en) | Attenuated human immunodeficiency virus vaccine | |
AU4399197A (en) | Hepatitis c virus epitope | |
AU3930895A (en) | Viral preparations, immunogens, and vaccines | |
AU4270896A (en) | Vaccine against aids comprising a peptide sequence of hiv |